Stem, Inc. (STEM) Misses Q3 EPS by 32c, provides guidance

Stem, Inc. (NYSE: STEM) reported Q3 EPS of ($0.49), $0.32 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $133.7 million versus the consensus estimate of $180.14 million.

GUIDANCE:

Stem, Inc. sees FY2023 revenue of $513-613 million, versus the consensus of $603 million.

Non-GAAP Gross Margin (%) 15% - 20%

Bookings $1,400 - $1,600

For earnings history and earnings-related data on Stem, Inc. (STEM) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Goldman Sachs starts Viridien at Buy on exploration recovery, shares rise
• Medtronic jumps on earnings beat and raised guidance